Search results
Results from the WOW.Com Content Network
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. [1] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. [1] [2] In these situations they decrease the need for blood transfusions. [2]
This is a list of government and private hospitals in Malaysia. In December 2016, there were 135 public hospitals and 9 special medical institutions in Malaysia , which accommodated 42,000 beds. [ 1 ]
Malaysian drug traffickers (1 C, 10 P) P. Pharmacy in Malaysia (1 C) S. ... Pages in category "Drugs in Malaysia" This category contains only the following page.
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs , ranked by sales.
Established in 1998, UMSC was initially located at University Malaya Medical Centre (UMMC) and in 2007 shifted to UMSC's own building. It is adjacent to the largest teaching hospital in Malaysia, UMMC and Malaysia's oldest medical school, the Faculty of Medicine, University of Malaya founded in 1962 which shares its roots with the National University of Singapore's Yong Loo Lin School of Medicine.
A major problem with the health care sector is the lack of medical centres for rural areas, which the government is trying to counter through the development of and expansion of a system called "tele-primary care". [1] Another issue is the overprescription of drugs, though this has decreased in recent years. [11]
Icodextrin (INN, USAN) is a colloid osmotic agent, derived from maltodextrin, [1] used in form of an aqueous solution for peritoneal dialysis under the trade name Extraneal, [2] and after gynecological laparoscopic surgery for the reduction of post-surgical adhesions (fibrous bands that form between tissues and organs) under the trade name Adept.
Congressional Record 5827 updates the drug add-on payment. For 2008 the drug add-on payment to the composite payment rate increased from 14.9 percent to 15.5 percent. [2] In addition to the add-on payment adjustment, which applies nationally, the composite rate is adjusted up or down by a geographic wage adjustment.